Latest filing published 01 Apr 2026 for Starling Oncology, Inc..
Insider track record
No signal scores available.
Jeffrey Langsam: trading record in brief
This profile gathers the share dealings of Jeffrey Langsam in Starling Oncology, Inc. Between 21 May 2025 and 27 March 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 1 April 2026: a share grant, in Starling Oncology, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey Langsam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 70,270 shares0Common StockSEC:0001079973-26-000449:0
- 57,380 shares0Common StockSEC:0000935836-25-000396:0
2 of 2 declarations
